Catalent Pharma Solutions to Present at CBI Conference on Comparator Studies

Catalent to Present at CBI Conference on Comparator Studies Research Triangle Park, N.C., March 25, 2008 – Michael Barron, MBA, Account Director at Catalent Pharma Solutions, will be a presenter at The Center for Business Intelligence’s (CBI) 2nd Annual Conference on Comparator Studies on March 26-27, 2009 in Philadelphia, P.A. Barron is a member of Catalent’s Respiratory, Analytical and Biotechnology group with facilities in Research Triangle Park, N.C., San Diego, C.A., and Middleton, W.I. His presentation is titled "Collaborate With a Contract Lab to Execute the Analytical Aspects of Comparator Studies."

Presentation Abstract

When modifying a comparative agent, blinding strategies often have an impact on the stability of the original product. As a result, a variety of stability testing methods are utilized to ensure that the quality and intended purpose of the comparative agent has not been compromised. Because these tests are often conducted on a competitor’s product, trial sponsors don’t always utilize in-house staff for the required testing. In most cases, external labs are hired to conduct the stability testing. During this session, a speaker from a lab collaborates with an industry client to discuss their working relationship and analyze the required stability testing methods.

About Catalent

Headquartered in Somerset, New Jersey, Catalent Pharma Solutions is a leading provider of advanced dose form and packaging technologies, and development, manufacturing and packaging services for pharmaceutical, biotechnology and consumer healthcare companies in nearly 100 countries. Catalent applies its local market expertise and technical creativity to advance treatments, change markets and enhance patient outcomes. Catalent employs approximately 9,100 at more than 30 facilities worldwide and in fiscal 2008 generated more than $1.8 billion of annual revenue. For more information, visit www.catalent.com .